Every recalls & safety alerts report published for Dublin, Ohio, newest first.
An FDA enforcement report, recall number D-0711-2026, lists Major Pharmaceuticals recalling one lot of unit-dose levothyroxine tablets distributed nationwide, with the action listed as ongoing.
An FDA enforcement report lists an ongoing nationwide recall of unit-dose levothyroxine sodium tablets packaged and distributed by Major Pharmaceuticals, initiated July 13, 2026.
An FDA enforcement report published July 29, 2026 lists one lot of 50 mcg levothyroxine sodium tablets recalled nationwide as a subpotent drug.
The agency's enforcement report lists one lot of the thyroid medication, distributed nationwide, as recalled for being subpotent; the action is ongoing.
An FDA enforcement report lists an ongoing nationwide recall of one lot of Major Pharmaceuticals levothyroxine sodium tablets, initiated July 13, 2026.
An FDA enforcement report lists three lots of the 100-tablet unit-dose cartons recalled nationwide as subpotent, with the action ongoing.
Enforcement report D-0709-2026 lists an ongoing recall of 75 mcg levothyroxine sodium tablets packaged by Major Pharmaceuticals, initiated July 13, 2026.
An FDA enforcement report lists one lot of Levothyroxine Sodium Tablets, USP, 88 mcg recalled nationwide as subpotent, with the action ongoing.
The agency's enforcement report for recall D-0705-2026 lists one lot of 125 mcg levothyroxine sodium tablets, distributed nationwide, with the action ongoing.
An FDA enforcement report lists a nationwide recall of 125 mcg levothyroxine sodium unit-dose tablets packaged by Major Pharmaceuticals, initiated July 13, 2026.
The agency's enforcement report for recall number D-0704-2026 records an ongoing, nationwide recall of a single lot, initiated July 13, 2026.